Patents Assigned to Insugen, LLC
  • Marrow stem cell and pancreatic beta cell fusion cell useful for the treatment of diabetes
    Patent number: 8119120
    Abstract: Methods disclosed include methods of treating T1DM, said method comprising delivering a therapeutic amount of ?-MSC to a subject in need thereof. Further disclosed are fusion cells comprising and MSC and a second cell wherein the nuclei of the MSC and the second cell are not fused in the fusion cell.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: February 21, 2012
    Assignee: Insugen, LLC
    Inventor: Christof Westenfelder